Nova One Advisor

Global Alpha Mannosidosis Market Size, Share, Forecast Report, 2020-2027

Status: Published Category: Healthcare Insight Code: 2069 Format: PDF / PPT / Excel

Content


Warning: DOMDocument::loadHTML(): htmlParseEntityRef: expecting ';' in Entity, line: 9 in /home/multiwpmr/public_html/report-details.php on line 448

Warning: DOMDocument::loadHTML(): htmlParseEntityRef: no name in Entity, line: 36 in /home/multiwpmr/public_html/report-details.php on line 448

Warning: DOMDocument::loadHTML(): htmlParseEntityRef: no name in Entity, line: 42 in /home/multiwpmr/public_html/report-details.php on line 448

Warning: DOMDocument::loadHTML(): htmlParseEntityRef: no name in Entity, line: 45 in /home/multiwpmr/public_html/report-details.php on line 448
The report provides rational insights along with historical and forecast data to aid in better understanding of the Global Alpha Mannosidosis Market. The report provides a comprehensive analysis of key factors that are expected to drive the growth of the Alpha Mannosidosis market. This study also provides a detailed overview of the opportunities along with the current trends observed in the target market.

According to the report, the global alpha mannosidosis market was valued at US$ 7.6 Mn in 2018 and is projected to expand at a CAGR of 9.9% from 2019 to 2027.

Alpha-mannosidosis is a rare genetic disease caused by the deficiency of an enzyme called alpha-mannosidase

It is hereditary autosomal recessive disorder and both chromosome copies carry mutations in the alpha-mannosidase gene MAN2B1

Alpha-mannosidase breaks down oligosaccharides. The absence of enzyme leads to accumulation of oligosaccharides inside the cell, resulting in damage of tissues and organs and leading to cell death

Treatment of alpha-mannosidosis is suggestive and supportive. Therapy is focused at preventing and treating the difficulties of the disorder

Some of the therapies include Bone Marrow Transplant (BMT), Peripheral blood stem cell transplantation (PBSCT), Enzyme replacement therapy (ERT), Gene Therapy and others

The report covers major players operating in the market along with the key strategies implemented to achieve a competitive edge against a majority of the vendors which provides a competitive outlook of the industry. The competitive landscape further includes details about different players and their position on a global and a local level is also explained in detail in this compiled study. These insights were prepared through mapping business strategies and products that offer high revenue generation capacities. Key players of the global Alpha Mannosidosis market are included as given below:

The alpha mannosidosis market currently only one companyhaving their products marketed. However, many companies have their products in the clinical stages that would fuel the market growth. Zymenex is the leading player in the market focusing on R&D to fight genetic diseases.The company has developed Lamazym, a recombinant enzyme indicated for patients with alpha mannosidosis.

The global Alpha Mannosidosis market has been segmented as below:

Global Alpha mannosidosis Market, by Treatment Type

o Bone Marrow Transplant

o Enzyme Replacement Therapy

Global Alpha mannosidosis Market, by Indication

o Type I

o Type II

o Type III

Global Alpha mannosidosis Market, by End-user

o Hospitals

o Specialty Clinics

Global Alpha mannosidosis Market, by Region

o North America

? U.S.

? Canada

o Europe

? Germany

? U.K.

? France

? Italy

? Spain

? Rest of Europe

o Asia Pacific

? China

? India

? Japan

? Australia & New Zealand

? Rest of Asia Pacific

o Latin America

? Brazil

? Mexico

? Rest of Latin America

o Middle East & Africa

? GCC Countries

? South Africa

? Rest of Middle East & Africa

Reasons to Purchase this Report:

Estimates Alpha Mannosidosis development trends with SWOT analysis

Detailed business profiles including product offerings, recent developments, key financial information, and strategies employed by main market players

Analysis of various regions and countries that includes the demand and supply based actions, which consequently have a major influence on the market's expansion

Market dynamics scenario, along with growth opportunities for players in the years to come

Competitive landscape involving the market share of major players, along with the new projects and strategies adopted by players in the mentioned forecast period

Market segmentation analysis including qualitative and quantitative research incorporating the impact of economic and policy aspects

  • Insight Code: 2069
  • No. of Pages: 250
  • Format: PDF/PPT/Excel
  • Published: June 2020
  • Report Covered: [Revenue + Volume]
  • Historical Year: 2021-2023
  • Base Year: 2024
  • Estimated Years: 2025-2034